| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Aug 2024 | 6 Aug 2024 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th June 2024. 2. Any other matter with the permission of the Chair. | ||
| Board Meeting | 28 May 2024 | 17 May 2024 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1. To Consider and approve Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31, 2024. 2. Any other matter with the permission of the Chair. We wish to inform you that the meeting of the Board of Directors of the Company held Today i.e. Tuesday, May 28, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 2 p.m., and has transacted the following businesses: 1. Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2024 and Auditors Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2024. - The meeting of Board of Directors commenced at 2.00 pm and concluded at 5.30 pm. Read less.. (As Per BSE Announcement Dated on 28.05.2024) | ||
| Board Meeting | 12 Feb 2024 | 5 Feb 2024 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday 12TH February 2024 at A 601 Floor No.6 Kailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Gtandalone & Consolidated) for the Quarter Ended on 31st December 2023. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 5th February, 2024 we wish to inform you that a meeting of the Board of Directors of the Company was held on Monday, 12th February, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 5.30 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 31st December 2023 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 5.30 p.m. and concluded at 9.30 pm Please Find Attached Result (As per BSE Announcement Dated on 12/02/2024) | ||
| Board Meeting | 11 Nov 2023 | 2 Nov 2023 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday 11th November 2023 at A 601 Floor No.6 Kailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter and Half year Ended on 30th September 2023. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 2nd November, 2023 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 11th November, 2023 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 4.00 p.m. and has transacted the following:- 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2023 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 4.00 p.m. and concluded at 5.00 pm (As Per BSE Announcement dated on 11.11.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
